DOCSLIB.ORG

In This Issue…

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
In This Issue… AAI Councillors Visit Capitol Hill, Extol Value of NIH Research See page 3 N FASEB Celebrates Its Centennial 12 AAI Looks Back—The 1918–1919 In This Issue… on Capitol Hill Influenza Pandemic 2 2012 AAI Election Results N NCATS Forms Industry Partnership 14 2012 AAI Annual Meeting Highlights N Does Your Degree Impact Your ™ 3 Focus on Public Affairs: 22 IMMUNOLOGY 2012 Sponsors NIH Funding Prospects? N AAI Holds Special Session on 24 Grant & Award Deadlines N New Dual Use Research Policy NIH Peer Review 28 Meetings Calendar N NIH Director Collins on TV N AAI Research Advocacy Program Engages 5 Key Partners 7 2012 AAI Advanced Immunology Cover Image: Course Program N FY 2013 NIH Funding Bill Clears Galacidalacidesoxiribunucleicacid Senate Committee 8 Members in the News See page 3 for details. 2012 AAI Election Results AAI congratulates the following members on their election to offices and committees for terms commencing July 1, 2012, and extends a sincere thanks to all candidates for their willingness to run and serve if elected. President (2012–2013) Nominating Committee The American Association Gail A. Bishop, Ph.D. (2012–2013) of Immunologists Carver College of Medicine Pamela S. Ohashi, Ph.D., F.R.S.C., Chair 9650 Rockville Pike Distinguished Professor of Microbiology Senior Scientist and Director Bethesda, MD 20814-3994 and Internal Medicine and Holden Immune Therapy Program Tel: 301-634-7178 Chair of Cancer Biology Ontario Cancer Institute Fax: 301-634-7887 University of Iowa Michael Croft, Ph.D. E-mail: infoaai@aai.org www.aai.org Vice-President (2012–2013) Professor and Head, Division of Marc K. Jenkins, Ph.D. Immune Regulation Member Services La Jolla Institute for Allergy Distinguished McKnight Tel: 301-634-7195 and Immunology University Professor E-mail: members@aai.org Center for Immunology and JoAnne L. Flynn, Ph.D. Department of Microbiology Professor, Department of Microbiology The Journal of Immunology University of Minnesota Medical School and Molecular Genetics Tel: 301-634-7197 E-mail: infoji@aai.org Secretary-Treasurer (2012–2015) University of Pittsburgh School of Medicine www.jimmunol.org/ Mitchell Kronenberg, Ph.D. Richard M. Locksley, M.D. President and Chief Scientific Officer Investigator, Howard Hughes Council La Jolla Institute for Allergy Medical Institute President and Immunology Sandler Distinguished Professor Gail A. Bishop, Ph.D. Departments of Medicine and Councillor (2012–2016) Microbiology and Immunology Vice President Wayne M. Yokoyama, M.D. University of California, San Francisco Marc K. Jenkins, Ph.D. Investigator, Howard Hughes Mark J. Shlomchik, M.D., Ph.D. Past President Medical Institute Leslie J. Berg, Ph.D. Levin Professor of Medicine and of Professor of Laboratory Medicine Pathology and Immunology and Immunobiology Secretary-Treasurer Washington University School of Yale School of Medicine Mitchell Kronenberg, Ph.D. Medicine Program Committee (2012–2015) Councillors Awards Committee (2012–2015) Shane Crotty, Ph.D. Linda A. Sherman, Ph.D. Dan R. Littman, M.D., Ph.D. Cheong-Hee Chang, Ph.D. Associate Professor, Division of Arlene H. Sharpe, M.D., Ph.D. Professor, Department of Microbiology Vaccine Discovery Wayne M. Yokoyama, M.D. and Immunology La Jolla Institute for Allergy University of Michigan Medical School and Immunology Ex Officio Councillors Jeremy M. Boss, Ph.D. Finance Committee (2012–2015) Erika L. Pearce, Ph.D. Assistant Professor, Department of M. Michele Hogan, Ph.D. Andrea J. Tenner, Ph.D. Pathology and Immunology Leo Lefrançois, Ph.D. Professor and Associate Dean Washington University School of Medicine Paul E. Love, M.D., Ph.D. for Research School of Biological Sciences Publications Committee Executive Director University of California, Irvine (2012–2016) M. Michele Hogan, Ph.D. Ann J. Feeney, Ph.D. www.aai.org/ Professor, Department of Immunology and About/Departments-Staff Microbial Science The Scripps Research Institute Thank you to all members who invested in their profession and demonstrated their commitment to the AAI mission by voting in the election this year. 2 AAI Newsletter July/August 2012 FOCUS ON PUBLIC AFFAIRS AAI Holds Special Session on NIH Peer Review n May 5, 2012, the AAI Committee on Public OAffairs hosted a special session, NIH Peer Review: Understanding the New System, at IMMUNOLOGY 2012™ in Boston. The session provided attendees with an insider view of the current state of peer review at NIH and a look at how the peer review system may evolve in the coming years. of recruiting researchers to serve on study sections and discussed ways that CSR is making it easier for researchers to participate, including conducting more electronic reviews and holding one meeting a year on the West Coast. Nakamura acknowledged the concerns he has heard from AAI and others about the elimination of the A2 application. He noted that CSR is continuing to discuss amended applications, including whether the A2 should be reinstated or whether all amended applications should be eliminated (i.e., accept only NIH peer review session speakers Daniel Rotrosen, Richard “new” applications). Nakamura, Elizabeth Kovacs Daniel Rotrosen described the role of NIAID in The session, which was chaired by Derry NIH peer review, including how program officers at Roopenian, Ph.D., chair of the AAI Committee on NIH institutes can provide assistance to NIH grant Public Affairs (CPA), featured three guest speakers: applicants. Among other things, program officers can Richard Nakamura, Ph.D., acting director of the NIH tell researchers more about the review of their original, Center for Scientific Review (CSR); Daniel Rotrosen, unfunded application if they plan to revise and M.D., director of the Division of Allergy, Immunology, resubmit. Program officers also represent applicants and Transplantation at the National Institute of Allergy before the NIAID Advisory Council. and Infectious Diseases (NIAID); and Elizabeth Kovacs, Finally, Elizabeth Kovacs led a robust question- Ph.D., chair of the AAI Subcommittee on Peer Review and-answer period, which featured much discussion and Grant Submission. about the A2 application. When asked about the 1–9 Richard Nakamura’s presentation focused on the scoring system, Nakamura acknowledged that he has role of CSR in NIH peer review. He explained that CSR heard a number of concerns about this issue, receives all grant applications submitted to NIH but and, when pressed about why CSR can’t go back to a reviews only about 70 percent of those applications. 1–50 scoring system, Nakamura said that CSR might The rest are reviewed by individual institutes and have to consider returning to this scale. centers at NIH. He also talked about the challenge Continued on next page About the Cover: Also referred to as Homage to Crick Galacidalacidesoxiribunucleicacid and Watson (Discoverers of DNA), the painting reflects Salvador Dalí’s intense interest in science, beginning with (1962–1963) Oil on canvas 1 Planck’s quantum theory in 1940. By the early 1960s, Dalí 120 x 161 /2 inches was fascinated by genetics for the possibility of discovering © Salvador Dalí. Fundación Gala-Salvador Dalí, an intelligent design at work in the universe. This canvas, (Artist Rights Society), 2011 painted early in his “Nuclear Mysticism” period (1962 to 1978), is the artist’s tribute to Francis Crick and James D. Watson for Collection of the Salvador Dalí Museum, Inc., St. Petersburg, FL, 2011. discovering the double helix structure of desoxyribonucleic acid (DNA). The name of the painting incorporates a play on the names of the artist and his wife, Gala, whose back-turned figure displays prominently in the work. www.aai.org AAI Newsletter 3 FOCUS ON PUBLIC AFFAIRS (continued) AAI Research Advocacy Program Brings Five Key Advocacy Partners to IMMUNOLOGY 2012™ AI hosted its third Research Advocacy Program A(RAP) on May 7, 2012, at the IMMUNOLOGY 2012™ meeting in Boston. The RAP supports the attendance of policy leaders from relevant patient RAP participant Martha Nolan (left) speaking advocacy organizations and foundations at a special to meeting attendees about scientific and program, which provides them opportunity to learn funding opportunities with the Society for Women’s Health Research about basic immunology, meet and hear from leading researchers, discuss policy issues of mutual concern, and develop relationships with AAI and each other. This year, AAI was pleased to host representatives from the American Academy of Pediatrics; the Asthma and Allergy Foundation of America; The Lymphatic Research Foundation; the Society for Women’s Health Research; and Zero—the Project to End Prostate Cancer. The fact that this year’s RAP participants had diverse advocacy goals and strategies allowed for an interesting discussion. The program featured presentations on basic immunology by members of the AAI CPA. The speakers (Clifford Harding, M.D., RAP participant James Baumberger (right) speaking to Ph.D., Introduction to the Immune System; Susanna meeting attendees interested in the pediatric research Greer, Ph.D., Overreactions of the Immune Response; Lori Covey, Ph.D., Harnessing the Immune System to A highlight of the program was its “Meet the Fight Cancer; Elizabeth Kovacs, Ph.D., Immunology Advocacy Partners” roundtable session, during Research: Challenges and Opportunities) effectively which representatives from each of the participating communicated how the immune system relates to groups were available to talk with meeting attendees the diseases of concern to each of the participating about their organizations, including any research organizations. and funding opportunities that might be available. Senate Committee Increases NIH Budget for FY 2013; House Operating Under Lower Spending Levels he Senate Appropriations Committee approved The Senate Appropriations Committee bill Tits fiscal year (FY) 2013 appropriations (funding) earmarks much of the $100 million increase by bill for the Departments of Labor, Health and Human providing an additional $56.5 million to the National Services, Education, and Related Agencies (Labor- Center for Advancing Translational Sciences (NCATS), HHS) on June 14, 2012, by a vote of 16-14, on a party for a total NCATS budget of $631.3 million.
Load more

Recommended publications
  • 2008 Keio Medical Science Prize Winner Announcement
    FOR IMMEDIATE RELEASE http://www.keio.ac.jp/ October 2, 2008 2008 Keio Medical Science Prize Winner Announcement Keio University presents the “Keio Medical Science Prize” to researchers in recognition of their outstanding achievements in the fields of medical or life sciences. It is the only prize of its kind to be awarded by a Japanese university. The 13th Keio Medical Science Prize will be awarded to Dr. Fred H. Gage and Dr. Shimon Sakaguchi. Fred H. Gage, Ph.D. Adler Professor, Laboratory of Genetics, The Salk Institute for Biological Studies, U.S.A. For the discovery of physiological roles of adult neurogenesis in mammalian brain Shimon Sakaguchi, M.D., Ph.D. Professor, Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Japan For the discovery of regulatory T cells and their roles in immunological diseases Award Ceremony and Commemorative Symposium The award ceremony and a commemorative lecture given by the prize winners will be held on November 21, 2008 and a commemorative symposium will take place on November 22. Both events will be held at the Keio University School of Medicine (Shinanomachi Campus). Please contact below for any inquiries. (eg. interviews or photographs) Attachments : (1) About the Keio University Medical Science Fund (2)2008 Prize Winner: Fred H. Gage（Theme, CV, message） (3)2008 Prize Winner: Shimon Sakaguchi（Theme, CV, message） (4)2008 Keio Medical Science Prize Award Ceremony/Commemorative Lecture/ Commemorative Symposium Inquiries: Keio University Medical Science Fund（Ms. Masako Kawai, Ms. Akiko Murai） TEL: +81-3-5363-3609 URL: http://www.ms-fund.keio.ac.jp/prize/ FAX: +81-3-5363-3610 E-mail:k-msf@adst.keio.ac.jp 1/5 Attachment About the Keio University Medical Science Fund Background In 1994, Dr.
    [Show full text]
  • Curriculum Vitae
    Curriculum Vitae Name in Full: Shimon Sakaguchi Birth Date: January 19, 1951 Institutions Attended: Kyoto University Premedical Course 1970-1972 Kyoto University Medical School 1972-1976 Degrees Acquired: Doctor of Medicine (M.D.) 1976 Doctor of Philosophy (Ph.D.) 1983 Research and Professional Experiences: Resident, Department of Pathology, Kyoto University Medical School and Hospital 1976-1978 Visiting Investigator, Laboratory of Pathology Aichi Cancer Center Research Institute 1978-1981 Senior Research Fellow, Institute for Immunology Kyoto University Medical School 1981-1983 Joint Appointment at the Blood Transfusion Service, Kyoto University Hospital 1981-1983 Postdoctoral Fellow, Department of Immunology and Infectious Diseases, The Johns Hopkins Medical Institutions 1983-1985 Postdoctoral Fellow (Lucille P. Markey Scholar), Department of Biophysics The Johns Hopkins Medical Institutions 1986-1987 Visiting Scientist, Division of Immunology and Rheumatology, Stanford University Medical Center 1987-1989 Assistant Professor, Department of Immunology, Scripps Research Institute 1989-1991 Investigator, Science and Technology Agency of Japan 1992-1994 Head, Department of Immunopathology, Tokyo Metropolitan Institute of Gerontology 1994-1997 Chair and Professor, Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University 1998-2011 Director, Institute for Frontier Medical Sciences, Kyoto University 2007-2011 Visiting Professor, Institute for Frontier Medical Sciences, Kyoto University 2011-present Professor, Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University 2011-present Adjunct Professor of Oncology, Roswell Park Cancer Institute, USA 2012-present Vice-director, Immunology Frontier Research Center, Osaka University 2012 –present Distinguished Professor, Osaka University 2013-present President of Japanese Society of Immunologists 2016-present Awards and honors: Lucille P. Markey Scholar Award in Biomedical Science 1986 Mochida Science Award 2003 Cancer Research Institute’s William B.
    [Show full text]
  • Program Project Grant
    OMB No 0925-0001 and 0925-0002 (Rev 10/15 Approved Through 10/31/2018) __________________________________________________________________________________ BIOGRAPHICAL SKETCH NAME POSITION TITLE Associate Dean for Research and Graduate Marcia F. McInerney___________________ Studies (protected time for research) Distinguished University Professor eRA commons user name Medicinal and Biological Chemistry mmciner College of Pharmacy and Pharmaceutical Sciences University of Toledo EDUCATION/TRAINING INSTITUTION AND LOCATION YEAR(s) FIELD OF DEGREE STUDY University of Michigan Ph.D. 1989 Microbiology & Immunology Yale University School of Med. Postdoc 1989-1991 Immunobiology- Dr. Charles A Janeway Jr, Mentor Joslin Diabetes Center/Harvard School of Visiting Prof 1998-1999 Diabetes/ Medicine of Medicine/ Endocrinology Iacocca Fellow University of Michigan Visiting Prof 2008 Metabolism, of Internal Endocrinology, Medicine and Diabetes A. Personal Statement I have been involved for over 25 years in research on the autoimmune aspects of type 1 diabetes (T1D) and inflammation in type 2 diabetes (T2D). While in the Janeway Laboratory for my postdoctoral we were the first lab to show that islets in nonobese diabetic (NOD) mice did not express MHC class II molecules, but that expression of MHC class I increased significantly during the development of diabetes. Therefore, we established that beta cells were not presenting antigen to CD4 T cells (last publication listed). I have worked actively on autoimmunity in type 1 diabetes as evidenced by publications on autoantigens (insulin, glutamic acid decarboxylase), autoantibodies (anti-insulin receptor), T cells (CD8 and CD4), T cell clones and hybridomas (anti-insulin, antiGAD), humanized transgenic mice expressing the diabetes susceptibility DQ8 molecule that turned out to be an autoimmune model of human myocarditis, and the role of the insulin receptor in diabetes development which was supported by NIH.
    [Show full text]
  • RIKEN IMS Annual Report 2019 RIKEN IMS Annual Report 2019
    RIKEN IMS Annual Report 2019 RIKEN IMS Annual Report 2019 RIKEN Center for Integrative Medical Sciences RIKEN Center for Integrative Medical Sciences RIKEN Center for Integrative Medical Sciences Organization Chart Director Division of Genomic Medicine Tadashi Yamamoto Laboratory for Transcriptome Technology: Piero Carninci Nucleic Acid Diagnostic System Development Unit: Kengo Usui Laboratory for Cellular Function Conversion Technology: Harukazu Suzuki Preventive Medicine and Applied Genomics Unit: Hideya Kawaji Laboratory for Genome Information Analysis: Chung Chau Hon RIKEN-IFOM Joint Laboratory for Cancer Genomics: Yasuhiro Murakawa Deputy Directors Office of the Center Director Laboratory for Applied Computational Genomics: Michel De Hoon Laboratory for Genotyping Development: Yukihide Momozawa Piero Carninci Chikashi Terao Piero Carninci Laboratory for Single Cell Technologies: Laboratory for Statistical and Translational Genetics: Takeya Kasukawa Taisei Mushiroda Haruhiko Koseki Laboratory for Large-Scale Biomedical Data Technology: Laboratory for Pharmacogenomics: Jay W. Shin Taisei Mushiroda Kazuhiko Yamamoto Laboratory for Advanced Genomics Circuit: Laboratory for International Alliance on Genomic Research: Genetic Diagnosis Technology Unit: Kengo Usui Laboratory for Bone and Joint Diseases: Shiro Ikegawa Epigenome Technology Exploration Unit: Aki Minoda Laboratory for Genomics of Diabetes and Metabolism: Momoko Horikoshi Senior Advisor Laboratory for Comprehensive Genomic Analysis: Yasushi Okazaki Laboratory for Cardiovascular
    [Show full text]
  • Download Your Copy Now
    Boston Children’s Hospital and the Bold Ideas that Change the World 3 For the children, families, healers and scientists of Boston Children’s Hospital. Together, they break through the impossible to create healthier futures for all. Break Through: Boston Children’s Hospital and the Bold Ideas that Change the World Copyright © 2019 by Boston Children’s Hospital All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Editor and writer: Laurie Beckelman Designer: Mary Ann Guillette Contributing writer: Nicole Davis Published 2019 Second Edition 2019 Printed in Canada WITH GRATITUDE Generous donations from the following physician foundations, hospital departments and philanthropic funds fully supported publication of Break Through: Boston Children’s Hospital and the Bold Ideas that Change the World. Boston Children’s Heart Foundation Boston Children’s Hospital Department of Dentistry Boston Children’s Hospital Trust Boston Pediatric Neurosurgical Foundation Boston Plastic & Oral Surgery Foundation Children’s Hospital Department of Psychiatry Children’s Hospital Neurology Foundation Children’s Hospital Ophthalmology Foundation Children’s Hospital Pathology Foundation Children’s Hospital Pediatrics Associates Children’s Hospital Radiology Foundation Children’s Orthopaedic Surgery Foundation Children’s Sports Medicine Foundation Children’s Urological Foundation CHMC Anesthesia Foundation CHMC Cardiovascular Surgical Foundation CHMC Otolaryngologic Foundation
    [Show full text]
  • Submit Your Late Breaking Abstract!
    Volume 7 Issue 1 April 2015 NEWSLETTERA Quarterly Publication of the Society for Mucosal Immunology Lori Rathje Named Pillars In ICMI 2015 SMI at Featured SMI Executive Director Immunology Speakers Immunology 2015 Papers Submit your Late Breaking Abstract! Still want to present your science in Berlin? Submit your abstract to the only meeting that focuses exclusively on the mucosal immune system. Late breaking abstract submission closes on Wednesday, April 15th. Submit today! To submit your abstract, click here. July 14th - 18th • Berlin, Germany Lori Rathje, CAE Mucosal Immunology School: Named Executive Pillars in Immunology Director of SMI Mucosal Immunology School Chairs Ifor Williams, Chiara Romagnani, MD, PhD MD, PhD Emory Univeristy German Rheumatism Research Center Berlin Lori Rathje, CAE, has been named Executive SMI has programmed a one day Mucosal Immunology School: Pillars in Immunology, Director of the Society for which will take place on Tuesday, July 14, before ICMI 2015. The overall aim of this Mucosal Immunology. Lori program is to facilitate a deeper understanding of the fundamentals of the immune was previously Association Manager for SMI system at mucosal surfaces. It will provide a broad overview of several core mucosal and served in that position since 2008. immunology topics and has been designed for graduate students and post-docs who have recently entered the field, as well as more experience researchers who are “I am honored to serve as Execu- interested in a concise refresher course. tive Director of SMI, and to have The faculty of this special educational event is the opportunity to work with such comprised of outstanding international experts who have made seminal contributions to the field.
    [Show full text]
  • World Premier International Research Center Initiative (WPI) FY2014 WPI Project Progress Report (Post-Interim Evaluation)
    World Premier International Research Center Initiative (WPI) FY2014 WPI Project Progress Report (Post-Interim Evaluation) Host Institutio n Osaka University Host Institution Head Toshio Hirano Research Cente r Immunology Frontier Research Canter Center D ire ctor Shizuo Akira Common instructions: * Unless otherwise specified, prepare this report from the timeline of 31 March 2015. * So as to base this fiscal year’s follow-up review on the document ”Post-interim evaluation revised center project,” please prepare this report from the perspective of the revised project. * Use yen (¥) when writing monetary amounts in the report. If an exchange rate is used to calculate the yen amount, give the rate. Summary of State of WPI Center Project Progress (write within two pages) IFReC was established as a leading Institute in Immunology and Medicine in Osaka University through the support of WPI program. Our institute provides a highly equipped research platform for young next generation researchers and world premier scientists who have contributed greatly in studies of cytokines, molecular mechanisms of innate immunity, cell death, and regulation of immune system. Our mission in WPI is to accelerate immunology research as well as develop fusion studies with other fields, systems reform of the host institute, and globalization of university and our society. Research of the highest world level: IFReC has continued to publish high quality research activities in highly reputable academic journals during FY2014 in innate immunity, acquired immunity, and the immune regulatory mechanism under the prominent leadership of center director Shizuo Akira, with 195 “WPI papers”, whose author(s) can be identified as affiliated with the WPI program.
    [Show full text]
  • Bridging Innate and Adaptive Immunity
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Leading Edge BenchMark Bridging Innate and Adaptive Immunity William E. Paul1,* 1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1892, USA *Correspondence: wpaul@niaid.nih.gov DOI 10.1016/j.cell.2011.11.036 The Nobel Prize in Physiology or Medicine for 2011 to Jules Hoffmann, Bruce Beutler, and the late Ralph Steinman recognizes accomplishments in understanding and unifying the two strands of immunology, the evolutionarily ancient innate immune response and modern adaptive immunity. Among the 15 Nobel prizes given for siveness. The celebration of immunolo- the eponymous complete Freund’s adju- discoveries in immunology, including the gists everywhere in response to this vant, consisting of killed Mycobacteria very first, the 2011 prize can be best well-deserved prize is tempered with tuberculosis organisms in a water-in-oil compared to the 1908 prize, shared by sadness, with Ralph Steinman having emulsion. two giants of modern science, Paul died on the Friday preceding the Monday Although this need to use adjuvants to Ehrlich and Ilya Metchnikoff. In awarding announcement of the award. obtain a robust immune response to that prize, the Nobel committee attemp- protein antigens was widely appreciated, ted to grapple with the divide that had Exploring Immunology’s ‘‘Dirty it was papered over as immunologists’ already arisen in the then infant
    [Show full text]
  • Osaka University Freedom and Enthusiasm
    Osaka University Freedom and enthusiasm . Where people grow and dream. Tekijuku(適塾) Koan Ogata(緒方洪庵) A pioneer in Japanese modern medical science Medicine Science Engineering Yuichi Shiro Engineering Nobuaki Yamamura IMCB Akabori Science KiKumagai Innovation by fusion World leading immunologists A pioneer in imaging Kishimoto Akira Yanagida Order of culture NAS member The imperial prize The imppperial prize Immunology Frontier Research Center World Premier Initiative (WPI) Program Why is a spatiotemporal approach important in immunology? Innate response Adaptive response Dynamic immune cellular networks Characteristics of immune system T cell differentiation • Largg(e number (1011))y and variety of cells • Migration whole through the body • Dynamic cellular interaction A variety of immune cells move around and form a dynamic network in the body Individual cells are influenced byyg interacting with other cells in the network The balance of immune resppyonses in the body cannot be deduced from isolated cell studies Imaging of spatiotemporal immune reactions in the body Development of imaging techniques Single molecule imaging Multiphoton microscopy MRI (11.7T) ligand GPCR PIP2 Lymph node PTEN Lyypmph node PIP3 Intracellular signaling Cell movement and interaction Immune cell localization From immuno-imaging to translational research Imaging of the immune system Evaluation of cancer immunotherapy Patterning of immune cell dynamics Imaging of lymph node Therapy Cancer- Normal Cancer Allergy attacking T cell Autoimmune disease Cancer Successful
    [Show full text]
  • World Premier International Research Center Initiative (WPI) Executive Summary (For Final Evaluation)
    World Premier International Research Center Initiative (WPI) Executive Summary (for Final Evaluation) Host Institution Osaka University Host Institution Head Shojiro Nishio Research Center Immunology Frontier Research Center Center Director Shizuo Akira About filling out this form: This summary is to be based on the Center’s Progress Report and Progress Plan, with reference to the following items, prepare the summary within a space of up to 6 pages. A. Progress Report of the WPI Center I. Summary IFReC was started as a sustainable innovative World Premier Institute of immunology in Osaka University. Our mission as a WPI is to accelerate immunology research as well as develop interdisciplinary studies with other fields, globalization of the university and our society, and system reform of the host institute. Headed by Director Shizuo Akira, an eminent immunologist, IFReC convenes approximately 30 of the world’s top-class principal investigators from Japan and overseas in the fields of immunology, live imaging and bioinformatics to conduct innovative immunological research. In March 2011, a new research building was completed on Osaka University’s Suita Campus providing superior research facilities and an international environment in which to focus on research. Immunology is definitely important in human health and social welfare. The researchers of IFReC have published over one thousand papers during 2007 to 2015. Almost 10% of them were published in high-impact journals such as Science, Cell, Nature, and their journal families. The production of Top 1% and Top 10% articles are much higher than average. The amount of competitive research funds obtained by IFReC researchers well exceeds the WPI program subsidy.
    [Show full text]
  • Harvard University History of Named Chairs
    HARVARDUNIVERSITY HISTORYOF NAMEDCHAIRS Sketches of Donors and Donations PROFESSORSHIPS OF THE FACULTIES OF MEDICINE AND PUBLIC HEALTH 1721 – 1992 CAMBRIDGE, MASSACHUSETTS 2005 Copyright © 2005 President and Fellows of Harvard College For additional copies, contact Harvard University Alumni Affairs and Development, at 1-800-VERITAS. Contents Foreword . vii Professorships of the Faculty of Medicine Harriet Ryan Albee Professorship . 3 American Cancer Society Research Professorships . 4 John Emory Andrus Professorship of Genetics . 6 Julia Dyckman Andrus Professorship of Pediatric Surgery . 7 William Applebaum Professorship . 10 Edith M. Ashley Professorship . 13 K. Frank Austen Professorship in Medicine . 15 W. H. Baker Professorship of Gynecology . 17 Theodore Bevier Bayles Professorship of Medicine . 20 Baruj Benacerraf Professorship in Pathology . 22 Helen Andrus Benedict Professorship of Surgery . 26 William Berenberg Professorship in Pediatrics . 27 George Packer Berry Professorship . 30 Herrman Ludwig Blumgart Professorship of Medicine . 33 John B. and Buckminster Brown Professorship of Orthopedic Surgery . 36 Bullard Professorship of Neuroanatomy . 39 Bullard Professorship of Neuropathology . 41 Bullard Professorship of Psychiatry . 44 Paul C. Cabot Professorship of Medicine . 46 William Bosworth Castle Professorship of Medicine . 50 Benjamin Castleman Professorship . 53 William Ellery Channing Professorship of Medicine . 56 William F. Chatlos Professorship of Ophthalmology . 58 Cheever Professorship of Surgery . 60 Edward D. Churchill Professorship of Surgery . 63 Stanley Cobb Professorship of Psychiatry and Psychobiology . 65 David G. Cogan Professorship of Ophthalmology . 69 Elliott Carr Cutler Professorship of Surgery . 73 Herman Dana Professorship of Medicine . 77 Julieanne Dorn Professorship of Neurology . 80 A. Werk Cook Professorship . 83 Philip H. Cook Professorship of Radiology . 85 Bronson Crothers Professorship of Neurology .
    [Show full text]
  • Preliminary Program
    Preliminary Program Monday, June 22 7:00 AM – 5:00 PM Registration Desk Open (4th Floor) FOCISed Courses (separate registration required) 7:30 AM – 5:00 PM Systems Immunology Course 8:00 AM – 5:30 PM Basic Immunology in Medicine: Update 2020 Course Tuesday, June 23 7:00 AM – 5:00 PM Registration Desk Open (4th Floor) FOCISed Courses (separate registration required) 8:00 AM – 12:00 PM Big Data ImmPort Workshop Sponsored by ImmPort. Supported by National Institute of Allergy and Infectious Diseases (NIAID) 8:00 AM – 4:30 PM Cancer Immunity & Immunotherapy Course Organized in collaboration with Society of Immunotherapy of Cancer (SITC) Member Society Symposia (included in FOCIS 2020 registration) 8:00 AM – 11:30 AM TBD FCE Fusion: Careers. Collaboration. Connection. (Invitation Only) 11:30 AM – 1:30 PM Member Society Symposia 12:30 PM – 4:00 PM TBD Updated December 18, 2019 Preliminary Program Opening Keynote Address 4:30 PM – 5:15 PM Opening Keynote Address Tasuku Honjo, MD, PhD, Kyoto University Opening Exhibit and Poster Reception (authors present) 5:15 PM – 6:45 PM Opening Reception: Exhibits & Poster Presentations Network with attendees while visiting exhibits and posters with authors present. Complimentary light hors d’oeuvres and wine served. FOCIS Member Reception (FOCIS members only) 7:00 PM – 8:00 PM Join us for hors d’oeuvres, drinks and fun! Let FOCIS show you how much we value you! Not a member? Join now at the registration desk. Wednesday, June 24 7:00 AM – 5:00 PM Registration Desk Open (4th Floor) Plenary Sessions 8:00 AM – 9:30 AM FOCIS 20th Anniversary 8:00 AM Title TBD Maria-Grazia Roncarolo, MD, Stanford University 8:30 AM Title TBD C.
    [Show full text]